Short Interest in Rafael Holdings, Inc. (NYSE:RFL) Declines By 44.7%

Rafael Holdings, Inc. (NYSE:RFL) was the target of a large decrease in short interest in the month of December. As of December 15th, there was short interest totaling 40,257 shares, a decrease of 44.7% from the November 30th total of 72,743 shares. Currently, 0.1% of the company’s shares are sold short. Based on an average daily volume of 210,772 shares, the days-to-cover ratio is presently 0.2 days. Based on an average daily volume of 210,772 shares, the days-to-cover ratio is presently 0.2 days. Currently, 0.1% of the company’s shares are sold short.

Rafael Price Performance

NYSE RFL opened at $1.19 on Friday. The company has a market cap of $61.61 million, a P/E ratio of -1.40 and a beta of 0.69. The stock has a 50-day moving average of $1.29 and a two-hundred day moving average of $1.54. Rafael has a 1-year low of $1.15 and a 1-year high of $3.19.

Rafael (NYSE:RFL) last posted its quarterly earnings data on Wednesday, October 29th. The company reported ($0.28) EPS for the quarter. Rafael had a negative net margin of 3,044.70% and a negative return on equity of 32.82%. The business had revenue of $0.89 million during the quarter.

Analysts Set New Price Targets

RFL has been the topic of a number of recent analyst reports. Wall Street Zen cut shares of Rafael from a “hold” rating to a “sell” rating in a research report on Friday, September 5th. Weiss Ratings reissued a “sell (e+)” rating on shares of Rafael in a research note on Monday. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, Rafael presently has an average rating of “Sell”.

Institutional Investors Weigh In On Rafael

Large investors have recently bought and sold shares of the stock. Vanguard Group Inc. raised its position in Rafael by 10.5% in the 3rd quarter. Vanguard Group Inc. now owns 1,394,726 shares of the company’s stock valued at $1,897,000 after purchasing an additional 133,024 shares in the last quarter. Geode Capital Management LLC raised its holdings in Rafael by 72.9% in the second quarter. Geode Capital Management LLC now owns 451,139 shares of the company’s stock valued at $781,000 after acquiring an additional 190,179 shares in the last quarter. Ieq Capital LLC purchased a new position in Rafael in the first quarter worth approximately $447,000. Cable Car Capital LP purchased a new position in Rafael in the second quarter worth approximately $173,000. Finally, Citadel Advisors LLC grew its holdings in Rafael by 132.3% during the 3rd quarter. Citadel Advisors LLC now owns 72,584 shares of the company’s stock worth $99,000 after acquiring an additional 41,335 shares in the last quarter. Hedge funds and other institutional investors own 11.30% of the company’s stock.

About Rafael

Rafael Holdings, Inc primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), currently under Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia.